These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

572 related items for PubMed ID: 21490337

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Individual red blood cell fetal hemoglobin quantification allows to determine protective thresholds in sickle cell disease.
    Hebert N, Rakotoson MG, Bodivit G, Audureau E, Bencheikh L, Kiger L, Oubaya N, Pakdaman S, Sakka M, Di Liberto G, Chadebech P, Vingert B, Pirenne F, Galactéros F, Cambot M, Bartolucci P.
    Am J Hematol; 2020 Nov; 95(11):1235-1245. PubMed ID: 32681733
    [Abstract] [Full Text] [Related]

  • 23. Fetal hemoglobin in sickle cell anemia: Bayesian modeling of genetic associations.
    Sebastiani P, Wang L, Nolan VG, Melista E, Ma Q, Baldwin CT, Steinberg MH.
    Am J Hematol; 2008 Mar; 83(3):189-95. PubMed ID: 17918249
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Fetal hemoglobin in sickle cell anemia.
    Steinberg MH.
    Blood; 2020 Nov 19; 136(21):2392-2400. PubMed ID: 32808012
    [Abstract] [Full Text] [Related]

  • 28. Physiologic decline in fetal hemoglobin parameters in infants with sickle cell disease: implications for pharmacological intervention.
    Marcus SJ, Ware RE.
    J Pediatr Hematol Oncol; 1999 Nov 19; 21(5):407-11. PubMed ID: 10524455
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Hydroxyurea in sickle cell disease--a study of clinico-pharmacological efficacy in the Indian haplotype.
    Italia K, Jain D, Gattani S, Jijina F, Nadkarni A, Sawant P, Nair S, Mohanty D, Ghosh K, Colah R.
    Blood Cells Mol Dis; 2009 Nov 19; 42(1):25-31. PubMed ID: 18954999
    [Abstract] [Full Text] [Related]

  • 34. Sickle cell disease in Saudi Arabia: the phenotype in adults with the Arab-Indian haplotype is not benign.
    Alsultan A, Alabdulaali MK, Griffin PJ, Alsuliman AM, Ghabbour HA, Sebastiani P, Albuali WH, Al-Ali AK, Chui DH, Steinberg MH.
    Br J Haematol; 2014 Feb 19; 164(4):597-604. PubMed ID: 24224700
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease.
    Lettre G, Sankaran VG, Bezerra MA, Araújo AS, Uda M, Sanna S, Cao A, Schlessinger D, Costa FF, Hirschhorn JN, Orkin SH.
    Proc Natl Acad Sci U S A; 2008 Aug 19; 105(33):11869-74. PubMed ID: 18667698
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Modulation of fetal hemoglobin in sickle cell anemia.
    Steinberg MH.
    Hemoglobin; 2001 May 19; 25(2):195-211. PubMed ID: 11480781
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.